After the capital increase, the total nominal value of Bavarian Nordic A/S' share capital is DKK 788,548,570, which is made up of 78,854,857 shares of a nominal value of DKK 10 each, corresponding to ...
ZUG, Switzerland, Nov. 29, 2024 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting of earnout shares and associated removal of restrictions on these ordinary shares.
Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response ...
Scott Wolchko To Retire as President and CEO after 10 years of Leadership in Pioneering iPSC-derived Cellular Immunotherapies SAN DIEGO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc.
TORONTO, Nov. 28, 2024 (GLOBE NEWSWIRE) -- New research released today by the Healthcare of Ontario Pension Plan (HOOPP) and Angus Reid Group suggests that employee burnout is a major concern among ...
Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that following the contract renewal with the China National Healthcare Security Administration (“NHSA”), the updated National ...
The Units will be sold on a non-brokered “private placement” basis in accordance with applicable Canadian securities laws and under applicable exemptions from prospectus and registration requirements ...